Chemotherapy as adjuvant therapy for completely resected non-small-cell lung cancer: Have we made progress?

被引:10
作者
Feld, R
机构
关键词
D O I
10.1200/JCO.1996.14.4.1045
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:1045 / 1047
页数:3
相关论文
共 18 条
[1]
ALBERTI W, 1995, BRIT MED J, V311, P899
[2]
[Anonymous], 1995, Eur J Surg Oncol, V21, P69
[3]
ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN IN PATIENTS WITH COMPLETELY RESECTED STAGE-I NON-SMALL-CELL LUNG-CANCER [J].
FELD, R ;
RUBINSTEIN, L ;
THOMAS, PA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (04) :299-306
[4]
SITES OF RECURRENCE IN RESECTED STAGE-I NON-SMALL-CELL LUNG-CANCER - A GUIDE FOR FUTURE STUDIES [J].
FELD, R ;
RUBINSTEIN, LV ;
WEISENBERGER, TH .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) :1352-1358
[5]
SURGICAL ADJUVANT THERAPY FOR STAGE-II AND STAGE-III ADENOCARCINOMA AND LARGE-CELL UNDIFFERENTIATED CARCINOMA [J].
HOLMES, EC .
CHEST, 1994, 106 (06) :S293-S296
[6]
Hryniuk W M, 1988, Important Adv Oncol, P121
[7]
ICHINOSE Y, 1995, CANCER, V75, P2677, DOI 10.1002/1097-0142(19950601)75:11<2677::AID-CNCR2820751106>3.0.CO
[8]
2-D
[9]
JOHNSON DH, 1994, CHEST, V106, pS313
[10]
LAD T, 1988, J CLIN ONCOL, V6, P9